Effect of nedocromil sodium and cromoline sodium on atopic basophil function

S. Kivity, O. Agami, M. Topilsky, E. Fireman

Research output: Contribution to journalArticlepeer-review


Nedocromil sodium (NS) is a new drug for the treatment of bronchial asthma. In the present study, we examined the effect of NS on basophil histamine release stimulated by anti-IgE, anti-IgE + IL-3 (interleukin-3) or ryegrass. The effect of cromoline Na (CrS) on histamine release from basophils to the same stimuli was compared. NS did not affect histamine release from basophils following anti-IgE alone or together with IL-3, but augmented the release following ryegrass. CrS did not affect histamine release after the same three stimuli. We concluded that NS and CrS do not affect bronchial asthma through direct inhibition of histamine release from basophils. Their action may be via an indirect effect on histamine-releasing factor.

Original languageEnglish
Pages (from-to)75-78
Number of pages4
JournalInternational Journal of Immunopharmacology
Issue number1
StatePublished - Jan 1996
Externally publishedYes


  • basophils
  • bronchial asthma
  • cromoline sodium
  • histamine
  • nedocromil sodium


Dive into the research topics of 'Effect of nedocromil sodium and cromoline sodium on atopic basophil function'. Together they form a unique fingerprint.

Cite this